What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose that the company's Principal Executive Officer and Principal Financial Officer submitted sworn statements to the SEC as required by SEC Order No. 4-460. It is a procedural disclosure related to regulatory compliance.

What is SEC Order No. 4-460?

SEC Order No. 4-460 is the specific regulatory order under which the company's officers were required to submit sworn statements to the Securities and Exchange Commission. The details of this order are not provided in the 8-K filing itself.

Does this filing contain any financial performance information or business updates?

No, this 8-K filing does not contain any financial performance information or strategic business updates. Its content is limited to the disclosure of the submission of sworn statements by company officers to the SEC.

Where can I find the content of the sworn statements submitted by the officers?

The sworn statements submitted by the Principal Executive Officer and Principal Financial Officer are attached as Exhibits 99.1 and 99.2 to this 8-K filing, which are publicly available through the SEC's EDGAR database.

ELV 8-K SEC Disclosure

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed a Form 8-K on August 5, 2002, primarily to disclose that its Principal Executive Officer, Larry C. Glasscock, and Principal Financial Officer, Michael L. Smith, submitted sworn statements to the SEC. This action was taken pursuant to SEC Order No. 4-460, a regulatory requirement. While the filing itself does not contain financial performance data or strategic updates, the submission of these sworn statements under SEC Order No. 4-460 suggests the company was responding to specific regulatory inquiries or mandates at the time. Investors should note that this filing is procedural and that the substantive details of the sworn statements are not disclosed within this 8-K, but are available as exhibits.

Key Highlights

1Company filed an 8-K on August 5, 2002.
2The filing pertains to Regulation FD Disclosure.
3Principal Executive Officer, Larry C. Glasscock, submitted a sworn statement to the SEC.
4Principal Financial Officer, Michael L. Smith, submitted a sworn statement to the SEC.
5These submissions were made pursuant to SEC Order No. 4-460.
6The sworn statements are attached as exhibits (99.1 and 99.2) to the filing.

Elevance Health, Inc. 8-K Report (Aug 5, 2002)

Summary

Key Highlights

Frequently Asked Questions